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Abstract  
 
Purpose: We sought to develop dual-modality imaging probes using functionalized silica 
nanoparticles to target human HER2-overexpressing breast cancer cells and achieve 
efficient target imaging of HER2-expressing tumors.  
 
Procedures: Polyamidoamine-based functionalized silica nanoparticles (PCSNs) for 
multimodal imaging were synthesized with near-infrared (NIR) fluoresce (indocyanine 
green (ICG)) and 99mTc radioactivity. Anti-HER2 antibodies were bound to the labeled 
PCSNs. These dual-imaging probes were tested to image HER2-overexpressing breast 
carcinoma cells. In vivo imaging was also examined in breast tumor xenograft models in 
mice.  
 
Results: SK-BR3 (HER2 positive) cells were imaged with stronger NIR fluorescent 
signals than that in MDA-MB231 (HER2 negative) cells. The increased radioactivity of 
the SK-BR3 cells was also confirmed by phosphor imaging. Pearl images showed 
strong fluorescent signals in the SK-BR3 tumor model compared to muscle tissue and 
the MDA-MB231 tumor model. Automatic well counting results showed increased 
radioactivity in some of the SK-BR3 xenograft tumors. 
 
Conclusions: We developed functionalized silica nanoparticles loaded with 99mTc and 
ICG for the targeting and imaging of HER2-expressing cells. The dual-imaging probes 
efficiently imaged HER2-overexpressing cells. Although further studies are needed to 
produce stable isotope labeling, the results suggest that the multifunctional silica 
nanoparticles are a promising vehicle for imaging specific components of the cell 
membrane in a dual-modality manner.    
